2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients

NCT06432166 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Mild Cognitive Impairment

Interventions

DRUG: 2-hydroxybenzylamine acetate
OTHER: Placebo

Sponsor

MTI Biotech Inc

Collaborators

[object Object]